Skip to main content

9 Result(s)

within K Moser Remove this filter English Remove this filter Hematology Remove this filter

and

  1. No Access

    Article

    Successful immunotherapy in early relapse of acute myeloid leukemia after nonmyeloablative allogeneic stem cell transplantation

    We report on a 35-year-old woman who underwent allogeneic stem cell transplantation (SCT) in second complete remission (CR) of acute myeloid leukemia (AML) after reduced-intensity conditioning with fludarabine...

    E. Prinz, F. Keil, P. Kalhs, M. Mitterbauer, W. Rabitsch… in Annals of Hematology (2003)

  2. No Access

    Article

    Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants

    We analyzed toxicity and efficacy of chemotherapy (CT) or second stem cell transplantation (SCT) and/or immunotherapy defined as stop of immunosuppression (IS) or donor leukocyte infusion (DLI) in 47 patients ...

    F Keil, E Prinz, P Kalhs, K Lechner, K Moser, I Schwarzinger, U Jäger… in Leukemia (2001)

  3. No Access

    Article

    Hematopoietic donor chimerism and graft-versus-myeloma effect in relapse of multiple myeloma after allogeneic bone marrow transplantation

     A large group of patients relapsing after allogeneic bone marrow transplantation (BMT) have obtained remission after infusion of leukocytes from their original donor, suggesting a graft-versus-myeloma effect....

    F. Keil, P. Kalhs, X. Chen, O. A. Haas, G. Fritsch, A. Chott… in Annals of Hematology (1999)

  4. No Access

    Article

    Toxicity and response to high-dose ifosfamide+mesna as salvage therapy for advanced breast cancer

    Twenty-six cycles of high-dose ifosfamide+mesna (HD-IFO+M) were applied to seven female patients with advanced breast cancer refractory to prior treatment, using three different durations of continuous infusio...

    G. G. Steger, C. Dittrich, O. Schlappack… in Journal of Cancer Research and Clinical On… (1988)

  5. Article

    Results of a four-year prospective randomised study of operable breast cancer

    R. Kolb, K. Kühnl-Brady, R. Jakesz, K. Moser… in Journal of Cancer Research and Clinical On… (1986)

    Download PDF (128 KB)

  6. No Access

    Article

    Acute cardiac toxicity in patients after doxorubicin treatment and the effect of combined tocopherol and nifedipine pretreatment

    In two groups of female patients with metastatic breast cancer who had all been pretreated with doxorubicin (350 mg/m2), acute cardiac effects following i.v. doxorubicin bolus injection (60 mg/m2) were recorded o...

    R. Lenzhofer, U. Ganzinger, H. Rameis… in Journal of Cancer Research and Clinical On… (1983)

  7. No Access

    Article

    Noninvasive methods for the early detection of doxorubicin-induced cardiomyopathy

    Ninety-eight female patients (mean age 54 years) who underwent doxorubicin therapy because of metastatic breast cancer were submitted to radionuclide angiography at rest. Left ventricular ejection fractions (L...

    R. Lenzhofer, R. Dudczak, G. Gumhold… in Journal of Cancer Research and Clinical On… (1983)

  8. No Access

    Article

    The value of prognostic parameters for the stratification of advanced breast cancer patients

    One hundred seventy-five patients with metastatic breast cancer, treated with a combination chemotherapy (Cooper regimen), were analyzed retrospectively to identify the value of the traditional prognostic para...

    R. Mörz, M. Francesconi, M. Schemper… in Journal of Cancer Research and Clinical On… (1982)

  9. No Access

    Chapter and Conference Paper

    Plasmapheresis for Therapy in Patients with Metastasizing Solid Tumors

    The importance of immunological defence mechanisms in malignant diseases is generally accepted today. The observation that tumor progression leads to a decline of both general and tumor-specific immunity has b...

    H. Rainer, E. M. Kokoschka, M. Micksche, K. Moser, M. Colot in Therapeutic Plasma Exchange (1981)